Stericycle, Inc. (NASDAQ:SRCL) Position Boosted by Equitable Trust Co.

Equitable Trust Co. raised its holdings in shares of Stericycle, Inc. (NASDAQ:SRCL) by 7.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,120 shares of the business services provider’s stock after acquiring an additional 473 shares during the quarter. Equitable Trust Co.’s holdings in Stericycle were worth $353,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of SRCL. JPMorgan Chase & Co. grew its stake in Stericycle by 42.2% during the 1st quarter. JPMorgan Chase & Co. now owns 2,808,202 shares of the business services provider’s stock valued at $122,466,000 after acquiring an additional 833,215 shares in the last quarter. Lazard Asset Management LLC bought a new stake in shares of Stericycle in the 4th quarter valued at approximately $29,286,000. Ninety One UK Ltd bought a new stake in shares of Stericycle in the 3rd quarter valued at approximately $22,644,000. Millennium Management LLC bought a new stake in shares of Stericycle in the 4th quarter valued at approximately $24,363,000. Finally, Point72 Asset Management L.P. grew its stake in shares of Stericycle by 55,818.2% in the 2nd quarter. Point72 Asset Management L.P. now owns 445,668 shares of the business services provider’s stock valued at $20,697,000 after buying an additional 444,871 shares in the last quarter. Hedge funds and other institutional investors own 98.82% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. StockNews.com cut Stericycle from a “buy” rating to a “hold” rating in a research note on Tuesday, April 2nd. Stifel Nicolaus boosted their target price on Stericycle from $70.00 to $75.00 and gave the stock a “buy” rating in a report on Thursday, February 29th. Truist Financial boosted their target price on Stericycle from $50.00 to $57.00 and gave the stock a “hold” rating in a report on Thursday, February 29th. Wells Fargo & Company boosted their target price on Stericycle from $40.00 to $48.00 and gave the stock an “underweight” rating in a report on Friday, March 1st. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $69.00 target price on shares of Stericycle in a report on Thursday, March 7th. One analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat, Stericycle presently has an average rating of “Hold” and a consensus target price of $62.25.

Stericycle Stock Down 0.2 %

SRCL opened at $51.71 on Tuesday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.94 and a current ratio of 0.94. Stericycle, Inc. has a 1 year low of $37.78 and a 1 year high of $57.06. The stock’s 50 day simple moving average is $51.20 and its 200-day simple moving average is $47.70.

Stericycle (NASDAQ:SRCL) last released its quarterly earnings data on Wednesday, February 28th. The business services provider reported $0.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.47 by $0.07. Stericycle had a positive return on equity of 7.06% and a negative net margin of 0.80%. The business had revenue of $652.00 million for the quarter, compared to analysts’ expectations of $657.99 million. During the same period in the previous year, the business posted $0.60 earnings per share. Stericycle’s quarterly revenue was down 2.7% on a year-over-year basis. On average, analysts expect that Stericycle, Inc. will post 2.31 earnings per share for the current fiscal year.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.